ABSTRACT
I- 2 M*, whereas 5% and 11% were associated with LSECs. Uptake of RAP and  2 M* in the different liver cell population in vitro was specific and followed by degradation. The uptake of 125 I-RAP was not inhibited by ligands to known endocytosis receptors in LSECs, while uptake of 125 I- 2 M* was significantly inhibited by RAP, suggesting the involvement of LRP-1.
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Introduction
The liver represents a major cleaning station of the body, daily eliminating large amounts of circulating macromolecules. Liver sinusoidal endothelial cells (LSECs) are a specialized type of endothelium, lining the liver sinusoids, that use receptor-mediated endocytosis to take up and degrade numerous physiological and non-physiological soluble macromolecules and colloids from the blood [35] . In addition, through their fenestrations, LSECs act as a dynamic filter facilitating the exchange of substrates between blood and hepatocytes [47] .
Low density lipoprotein receptor-related protein-1 (LRP-1), a member of the LDL receptor family, is a large, multifunctional endocytic receptor expressed in liver parenchymal cells (PCs), neurons, activated astrocytes and fibroblasts [45] . LRP-1 is synthesized as a single polypeptide chain cleaved in the trans-Golgi to form a heterodimer of two noncovalently bound proteins, a 515 kDa subunit (-chain) containing its binding domains, and a 85 kDa subunit (-chain) containing the membrane-spanning region and cytoplasmic tail [18] . LRP-1 is known to interact and mediate endocytosis of more than 40 unrelated ligands ranging from proteins involved in lipoprotein metabolism, viruses to protease/protease inhibitor complexes cytokines, and growth factors [19] .
LRP-1 and other members of the LDL receptor family associate with a specific chaperone, receptor-associated protein (RAP). RAP binds LRP-1 at multiple sites to block its interaction with ligands during biosynthesis and traffic to the cell surface [4] .
Exogenous administration of RAP acts as a receptor antagonist for all ligands of the LDL receptor family, thus rendering RAP a valuable tool to study the LDL receptor gene 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60  61  62  63  64  65   5 family's biochemistry and to investigate potential specific interaction of ligands with LRP-1 and LRP-1 related proteins in vivo and in vitro [46] .
is a major human blood glycoprotein able to trap and inactivate a large variety of proteinases, and inhibit fibrinolysis by reducing plasminogen to kallikrein [41] . The  2 M-proteinase complex, the "activated"  2 M ( 2 M*), becomes a specific ligand for the LRP-1, and is eliminated from the circulation by LRP-mediated endocytosis and subsequently degraded [41] .  2 M was recently found to be a noninvasive serological biomarker that could predict the stage of liver fibrosis [20] The expression and function of the LRP-1 in liver was so far studied in PCs or PC-like cell lines [2, 6, 7, 42, 43] . Using RAP and  2 M* as potent ligands for LRP-1, we investigated whether this receptor is also expressed in LSECs .   1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60  61  62  63  64  65 6
Materials and Methods
Animals
Male Sprague-Dawley rats ( 250g) were from Scanbur BK AB (Sollentuna, Sweden). 
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(FSA) was prepared as described [31] . High molecular weight hyaluronan (HA) was from Pharmacia (Uppsala, Sweden). Collagen α-chains (α-coll) were obtained by incubation at 60  C for 60 min of native triple helical collagen (Vitrogen, Palo Alto, California).
Labeling Procedures
RAP and  2 M (50 g) in PBS were directly labeled with Na 125 I employing Iodogen as oxidizing agent [27] . Specific radioactivities were between 5 -8 x 10 6 cpm/g.  2 Mtrypsin complexes ( 2 M*) were prepared as described [16] . Briefly,  2 M or 125 I- 2 M was incubated with 2 fold molar trypsin for 5 min at RT, followed by addition of soybean trypsin inhibitor, 5 fold molar more than trypsin. The complex formation was tested by gelatin zymography. FSA in Na 2 CO 3 (0.1 M, pH 9.5) was incubated with TRITC at a ligand/dye weight ratio of 5:1, at 4C overnight and then dialyzed against PBS.
Anatomical Distribution
Anatomical distribution of intravenously (i.v.) administered 125 I-RAP and 125 I- 2 M* (0.5 g) were determined as described [38] . Total blood volume was calculated [44] .
Hepatocellular Distribution
Ten min after i.v. administration of 5 g of 125 I-RAP or 125 I- 2 M*, different liver cells were purified as described bellow. The uptake per cell population in the total liver was calculated based on the rat liver ratio KCs:LSECs:PCs=1:2.5:7.7 [33] . antibody [17, 28] . LSEC preparations were between 95-98% pure. The degree of LSEC contamination in KCs was less than 10%. Immunofluorescence staining for LRP-1
Isolation of PCs, LSECs and KCs
Kinetics and specificity of endocytosis
LSECs on fibronectin coated coverslips were incubated with TRITC-FSA for 1h at 37C. 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60  61  62  63  64  65 10 5% BSA and incubated overnight at 4C with 125 I-RAP before phosphorimaging (Fuji BAS5000).
Identification of LRP-1 by mass spectrometry
A band of > 500 kDa was excised from the silver-stained gel, reduced with DTT, alkylated with iodoacetamide and digested with trypsin [36] . Nano-LC-ESI-MSMS was performed (see supplementary materials and methods). Peak lists of MSMS spectra were generated with DTASuperCharge (http://msquant.sourceforge.net/) and searched with MASCOT against the mammalian part of the IPI_rat database.
LRP mRNA levels in PCs, LSECs and KCs
Total RNA was extracted from isolated PCs, Kupffer and LSECs using total RNA isolation kit from Macherey-Nagel (Duren, Germany). Approximately 2-10 million plated cells were lysed (PCs were in suspension). The quantity and quality of RNA was determined by Nanodrop (ThermoFisher Scientific, Wilmington, DE, USA) and by an electropheretic bioanalyzer Agilent 2100 using the Pico 6000 Assay (Agilent Technologies, Santa Clara, CA, USA). The 260/280 ratios in all samples were 2.1 and 18S/28S ratios were between 1. 12 
Results
Anatomical distribution in vivo of intravenously injected
Hepatocellular distribution
To determine which liver cells are responsible for RAP and  2 M* uptake, 125 I-RAP and 125 I- 2 M* were i.v injected into rats followed by liver perfusion with collagenase and isolation of PCs, LSECs and KCs by means of Percoll gradient and an antibody-based magnetic separation method (MACS). All steps were performed at 4C to prevent cellular loss of internalized ligand due to degradation. In the whole liver, 93.1±1% of RAP and 82.2±6%  2 M* was found associated with the PCs (Figure 2 ). The LSECs and KCs were further purified using specific antibodies [11] . The ICAM-1 positive cells (LSECs) were found to be responsible for 5.3 ± 1.3% of RAP uptake and 11.1 ± 6.7% of  2 M* uptake, while the CD11b positive cells (KCs), for 1.6 ± 0.2% and 6.8 ± 0.7%, respectively ( Figure 2 ). Figure 4B ). The presence of RAP had a significant inhibitory effect on both the cell associated and degraded 125 I- 2 M*, and it inhibited the total uptake by 50.1%
In vitro studies
(p<0.001), suggesting the involvement of the LRP-1 in uptake.
Immunofluorescence staining for LRP-1
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LRP-1 expression in liver cells
The expression of LRP in the different liver cells was assessed by extraction of mRNA and RT-PCR. We found that after normalizing for an internal mRNA control GAPDH (which showed minimum variation in samples), the LRP-1 expression levels in PCs were 6 times higher than in LSECs and KCs, with LSECs and KCs expressing approximately similar levels. To further confirm that LRP-1 is expressed in LSECs, total cell protein was incubated with Dynabeads coupled to RAP, to pull down the receptor/s binding RAP. Bound proteins were eluted from the beads, and run in parallel on two SDS-PAGE gels under non-reducing conditions. The proteins on the first gel were visualized by silver staining (Figure 6 .A). Dynabeads coupled to BSA were used as negative control showing that LRP-1 does not bind unspecifically to the beads. PCs and U87 cell line were used as positive controls, as both cell types are known to express LRP-1 [5, 34] . A band of > 500 kDa appeared on the silver stained gel from cell extracts of all three cell types ( Figure   6 .A). The proteins from the second gel were transferred to nitrocellulose filters and incubated with 125 I-RAP before phosphorimaging. The results presented in Figure 6 .B
show that 125 I-RAP bound to a single protein from the cell extracts of LSECs. The respective band corresponded to a similar band from the U87 and PCs extracts. A sensitive and specific high-performance liquid chromatography-tandem mass spectrometry using electrospray ionization (LC-ESI-MSMS) was chosen to study the band excised from the silver-stained gel. Rat LRP-1 (IPI00369995) was identified with a Mascot score of 134. Identified peptides are listed in Table 1 (supplementary material).   1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60  61  62  63  64 Several studies have shown that  2 M-protease complexes have a circulatory half-life of 2-4 min (for review, see [41] ), and RAP has a half-life of 0.5 min [43] . Using whole body autoradiography, it has been reported that the liver was the main site for uptake of both ligands [32, 43] . In this study we investigated the anatomical distribution by measuring the radioactivity in 15 organs, 10 min after intravenous injection. This method gives a better quantification of the distribution since the blood is washed out of the organs by systemic perfusion, and the radioactivity is measured in the total organ. Our results were 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60  61  62  63  64  65 17 in accordance with the previous findings, with the liver being the main site of uptake of 125 I-RAP and 125 I- 2 M*.
It has been previously reported that the liver PCs are the main site of uptake of  2 M* [10, 15] . The authors used autoradiography as a method for identifying the anatomical site of uptake. This technique, however, makes it difficult to distinguish between KCs and
LSECs. Since at that time (1985) it was generally believed that KC = liver reticuloendothelial system (RES), it is fully understandable that the authors did not suggest the possibility that LSECs could be an alternative site of uptake in addition to the KCs. It was not until 1990 that LSEC was proposed, based on a solid body of evidence, to be a very important part of the liver RES [40] . In our study, we have used an antibodybased purification method that allowed us to achieve higher purities and more defined cell populations. Our results show that LSECs also contributed to the elimination of RAP and  2 M* from the circulation, albeit to a lesser extent than PCs.
The most likely receptor candidate, LRP-1, has previously been shown to be expressed in the liver by PCs only [24, 34] . The following findings in the present study point to the To obtain direct evidence for identification of LRP-1 in LSECs and thereby rule out possible influence of marginal contamination of PCs, the cell cultures were pre-incubated 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60  61  62  63  64  65   18 with TRITC-FSA, a ligand that is known to be taken up only by the LSECs in the liver [12] . KCs. If the relative protein expression levels mirror the RNA levels, this may explain the differences between RAP and  2 M* uptake observed in the in vitro PC and non-PC cell assays. Another interesting finding was that the uptake capacity for RAP was higher in all three cell types as compared to that for  2 M*. This may be due to involvement of other receptor(s) that recognize RAP. Such receptor could be the LDL receptor [30] which is known to be expressed on PCs and is able to bind to RAP, although with less affinity than LRP-1 [3, 24] .
In conclusion, we demonstrate for the first time that the expression of functional LRP-1 in liver is not restricted only to PCs, it is also found in LSECs, and to a lesser extent in
KCs. Characterized by a very high endocytic activity [37] , LSECs would contribute 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60  61  62  63  64  65 19 significantly to the elimination of the various LRP-1 ligands from the circulation in normal, healthy conditions.
However, in pathological conditions, such as severe fatty liver diseases, as well as in aging [14, 21, 29] , significant changes occur in the hepatic sinusoids (e.g. fibrosis,
narrowing of the sinusoids, reduced blood flow and capillarization of the liver sinusoids).
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